Abstract | OBJECTIVE: To study the efficacy of reamberin in treatment of epilepsy in children and to evaluate its effect on the cognitive functions. MATERIAL AND METHODS: The study included 51 patients with epilepsy aged 7 to 15 years. The children were divided into four groups depending on the prescribed treatment. The first study group (n=16) received intravenous reamberin once daily for 5 days in addition to carbamazepine. The second group (n=15) received intravenous reamberin once daily for 5 days in addition to valproic acid. Two comparison groups (10 patients each) received only carbamazepine or only valproic acid, respectively. Cognitive functions were assessed at admission and on the 6th day of treatment using Schulte tables (10 words). RESULTS AND CONCLUSION:
Reamberin significantly increases the work efficiency by 19-21%, and workability degree by 8-12% compared with the patients of the control groups. An analysis of the effect of succinate-containing drug on auditory memory has shown that the volumes of short-term memory and long-term memory are by 1.8 times and 1.3 times, respectively, higher than those in the control groups. Thus, the addition of reamberin into the treatment of children with epilepsy should be considered clinically reasonable, and promising.
|
Authors | L A Nosal', N V Simonova, V A Dorovskikh |
Journal | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
(Zh Nevrol Psikhiatr Im S S Korsakova)
Vol. 120
Issue 11
Pg. 53-58
( 2020)
ISSN: 1997-7298 [Print] Russia (Federation) |
Vernacular Title | Opyt primeneniya reamberina dlya korrektsii kognitivnykh funktsii pri epilepsii u detei. |
PMID | 33340298
(Publication Type: Journal Article)
|
Chemical References |
- Anticonvulsants
- Reamberin
- Succinates
- Meglumine
|
Topics |
- Adolescent
- Anticonvulsants
(therapeutic use)
- Child
- Cognition
- Epilepsy
(drug therapy)
- Humans
- Meglumine
(analogs & derivatives, therapeutic use)
- Succinates
(therapeutic use)
|